Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Return on Capital Employed (2016 - 2024)

Historic Return on Capital Employed for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to 0.31%.

  • Trinity Biotech's Return on Capital Employed rose 2700.0% to 0.31% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.31%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.43% for FY2024, which is 200.0% up from last year.
  • As of Q4 2024, Trinity Biotech's Return on Capital Employed stood at 0.31%, which was up 2700.0% from 0.2% recorded in Q3 2024.
  • Trinity Biotech's Return on Capital Employed's 5-year high stood at 0.87% during Q2 2021, with a 5-year trough of 0.58% in Q4 2023.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.06% (2022), whereas its average is 0.05%.
  • As far as peak fluctuations go, Trinity Biotech's Return on Capital Employed surged by 8200bps in 2021, and later plummeted by -8600bps in 2022.
  • Trinity Biotech's Return on Capital Employed (Quarter) stood at 0.19% in 2020, then skyrocketed by 70bps to 0.33% in 2021, then crashed by -177bps to 0.25% in 2022, then tumbled by -134bps to 0.58% in 2023, then skyrocketed by 47bps to 0.31% in 2024.
  • Its Return on Capital Employed was 0.31% in Q4 2024, compared to 0.2% in Q3 2024 and 0.23% in Q2 2024.